Skip to content

Exome Asset Management LLC

Follow

13F filer, CIK 2011932, NEW YORK, NY

Exome Asset Management LLC reported $153,028,952 across 55 holdings for the quarter ended 2026-09-30, in a 13F-HR filed 2026-11-16. Its ten largest share positions make up 48.16% of the portfolio.

Accepted , ingested 13F-HR 0001420506-26-002739

Period
2026-09-30
Reported value
$153M
Holdings
55
Top 10 weight
48.16%
New
9
Sold out
6

Largest buys vs the previous quarter

SecurityShares changeApprox. value
ABVXadded+44,041$4.36M
VKTXadded+99,636$3.25M
NKTRadded+51,291$3.11M
CAIadded+67,913$2.08M
VERAadded+62,280$2.01M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
TXGreduced-72,555-$6.56M
AGIOexited-70,500-$2.62M
CBIOexited-127,769-$2.3M
AZNexited-12,045-$2.25M
QUREreduced-62,756-$1.52M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q3 2026

Share positions as resolved from 13F-HR 0001420506-26-002739, largest first. % of portfolio is the value over $153,028,952, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
GHGUARDANT HEALTH INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 147,800 shares; 2025Q1: 127,182 shares; 2025Q2: 98,182 shares; 2025Q3: 98,182 shares; 2025Q4: 98,182 shares; 2026Q1: 82,736 shares; 2026Q2: 67,500 shares; 2026Q3: 67,500 shares 67,500$12M7.87%0Timeline
TGTXTG THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 164,915 shares; 2026Q3: 187,671 shares 187,671$10.5M6.84%+22,756Timeline
ABVXABIVAX SAQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 46,878 shares; 2026Q3: 90,919 shares 90,919$9M5.88%+44,041Timeline
PRAXPRAXIS PRECISION MEDICINES IQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 59,002 shares; 2025Q3: 101,996 shares; 2025Q4: 58,122 shares; 2026Q1: 45,469 shares; 2026Q2: 27,205 shares; 2026Q3: 29,681 shares 29,681$8.64M5.65%+2,476Timeline
COGTCOGENT BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 621,678 shares; 2025Q2: 533,647 shares; 2025Q3: 443,547 shares; 2025Q4: 305,568 shares; 2026Q1: 278,533 shares; 2026Q2: 210,523 shares; 2026Q3: 210,523 shares 210,523$6.74M4.41%0Timeline
LLYELI LILLY & COQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 8,247 shares; 2025Q1: 4,673 shares; 2025Q2: 4,673 shares; 2025Q3: 7,852 shares; 2025Q4: 7,852 shares; 2026Q1: 7,012 shares; 2026Q2: 5,492 shares; 2026Q3: 5,492 shares 5,492$6.35M4.15%0Timeline
NTRANATERA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 22,450 shares; 2025Q1: 18,650 shares; 2025Q2: 18,650 shares; 2025Q3: 18,650 shares; 2025Q4: 18,650 shares; 2026Q1: 18,650 shares; 2026Q2: 13,800 shares; 2026Q3: 13,800 shares 13,800$5.7M3.73%0Timeline
VERAVERA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 76,700 shares; 2025Q3: 156,072 shares; 2025Q4: 124,391 shares; 2026Q1: 114,991 shares; 2026Q2: 97,276 shares; 2026Q3: 159,556 shares 159,556$5.15M3.37%+62,280Timeline
VKTXVIKING THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 47,861 shares; 2026Q3: 147,497 shares 147,497$4.81M3.14%+99,636Timeline
IONSIONIS PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 61,367 shares; 2025Q1: 135,616 shares; 2025Q2: 121,116 shares; 2025Q3: 131,016 shares; 2025Q4: 116,515 shares; 2026Q1: 110,064 shares; 2026Q2: 88,177 shares; 2026Q3: 107,034 shares 107,034$4.78M3.12%+18,857Timeline
ELVNENLIVEN THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 222,308 shares; 2026Q1: 220,091 shares; 2026Q2: 100,203 shares; 2026Q3: 100,203 shares 100,203$4.59M3%0Timeline
CAICARIS LIFE SCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 78,180 shares; 2026Q3: 146,093 shares 146,093$4.47M2.92%+67,913Timeline
NKTRNEKTAR THERAPEUTICSQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 22,417 shares; 2026Q3: 73,708 shares 73,708$4.46M2.92%+51,291Timeline
CYTKCYTOKINETICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 65,883 shares; 2025Q1: 103,483 shares; 2025Q2: 115,817 shares; 2025Q3: 142,417 shares; 2025Q4: 124,749 shares; 2026Q1: 103,718 shares; 2026Q2: 60,056 shares; 2026Q3: 60,056 shares 60,056$3.96M2.59%0Timeline
VSTMVERASTEM INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 599,900 shares; 2025Q3: not reported; 2025Q4: 401,743 shares; 2026Q1: 636,700 shares; 2026Q2: 429,041 shares; 2026Q3: 429,041 shares 429,041$3.45M2.26%0Timeline
MAZEMAZE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 88,510 shares; 2026Q2: 114,692 shares; 2026Q3: 114,692 shares 114,692$3.12M2.04%0Timeline
RYTMRHYTHM PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 40,581 shares; 2026Q2: 32,209 shares; 2026Q3: 32,209 shares 32,209$3.07M2%0Timeline
TXG10X GENOMICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 163,658 shares; 2025Q3: 163,658 shares; 2025Q4: 163,658 shares; 2026Q1: 154,194 shares; 2026Q2: 102,629 shares; 2026Q3: 30,074 shares 30,074$2.72M1.78%-72,555Timeline
ALKSALKERMES PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 84,103 shares; 2026Q2: 61,336 shares; 2026Q3: 61,336 shares 61,336$2.49M1.62%0Timeline
UTHRUNITED THERAPEUTICS CORP DELQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 6,645 shares; 2025Q4: 7,685 shares; 2026Q1: 7,053 shares; 2026Q2: 5,410 shares; 2026Q3: 4,109 shares 4,109$2.23M1.46%-1,301Timeline
BSXBOSTON SCIENTIFIC CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 40,500 shares; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 48,347 shares; 2026Q2: 48,347 shares; 2026Q3: 48,347 shares 48,347$2.11M1.38%0Timeline
ARWRARROWHEAD PHARMACEUTICALS INQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 104,507 shares; 2025Q4: 49,758 shares; 2026Q1: 45,721 shares; 2026Q2: 32,214 shares; 2026Q3: 32,214 shares 32,214$2.11M1.38%0Timeline
UNHUNITEDHEALTH GROUP INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 5,835 shares; 2026Q1: 12,862 shares; 2026Q2: 9,612 shares; 2026Q3: 5,697 shares 5,697$2.09M1.37%-3,915Timeline
OCULOCULAR THERAPEUTIX INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 181,588 shares; 2026Q3: 272,046 shares 272,046$2.09M1.36%+90,458Timeline
ALMSALUMIS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 292,770 shares; 2025Q4: 292,250 shares; 2026Q1: 279,176 shares; 2026Q2: 204,418 shares; 2026Q3: 282,253 shares 282,253$2.09M1.36%+77,835Timeline
PENPENUMBRA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 9,000 shares; 2025Q1: 9,000 shares; 2025Q2: 9,000 shares; 2025Q3: 9,000 shares; 2025Q4: 9,000 shares; 2026Q1: 6,300 shares; 2026Q2: 6,300 shares; 2026Q3: 6,300 shares 6,300$2.01M1.31%0Timeline
ISRGINTUITIVE SURGICAL INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 7,427 shares; 2025Q1: 6,358 shares; 2025Q2: 6,358 shares; 2025Q3: 6,358 shares; 2025Q4: 6,358 shares; 2026Q1: 6,358 shares; 2026Q2: 4,908 shares; 2026Q3: 4,908 shares 4,908$2M1.3%0Timeline
MLTXMOONLAKE IMMUNOTHERAPEUTICSQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 178,084 shares; 2025Q4: not reported; 2026Q1: 215,376 shares; 2026Q2: 166,493 shares; 2026Q3: 166,493 shares 166,493$1.95M1.27%0Timeline
CMPSCOMPASS PATHWAYS PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 213,544 shares; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 153,087 shares 153,087$1.9M1.24%newTimeline
CLDXCELLDEX THERAPEUTICS INC NEWQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 73,000 shares; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 56,269 shares 56,269$1.82M1.19%newTimeline
MRKMERCK & CO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 12,358 shares 12,358$1.8M1.17%newTimeline
LQDALIQUIDIA CORPORATIONQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 20,500 shares; 2025Q3: 94,235 shares; 2025Q4: 91,148 shares; 2026Q1: 45,796 shares; 2026Q2: 39,224 shares; 2026Q3: 59,155 shares 59,155$1.79M1.17%+19,931Timeline
GKOSGLAUKOS CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 27,143 shares; 2025Q4: 31,471 shares; 2026Q1: 20,874 shares; 2026Q2: 19,862 shares; 2026Q3: 10,862 shares 10,862$1.78M1.17%-9,000Timeline
GLUEMONTE ROSA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 179,484 shares; 2026Q2: 137,115 shares; 2026Q3: 137,015 shares 137,015$1.63M1.07%-100Timeline
BBIOBRIDGEBIO PHARMA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 246,700 shares; 2025Q1: 165,496 shares; 2025Q2: 155,533 shares; 2025Q3: 133,087 shares; 2025Q4: 80,723 shares; 2026Q1: 67,492 shares; 2026Q2: 18,359 shares; 2026Q3: 21,209 shares 21,209$1.4M0.91%+2,850Timeline
CLPTCLEARPOINT NEURO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 83,636 shares; 2026Q3: 110,174 shares 110,174$1.35M0.88%+26,538Timeline
CRBPCORBUS PHARMACEUTICALS HLDGSQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 289,690 shares; 2025Q2: 277,317 shares; 2025Q3: 229,962 shares; 2025Q4: 139,543 shares; 2026Q1: 234,136 shares; 2026Q2: 184,914 shares; 2026Q3: 190,714 shares 190,714$1.3M0.85%+5,800Timeline
CTMXCYTOMX THERAPEUTICS INC.Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 745,305 shares; 2025Q4: 745,305 shares; 2026Q1: 521,468 shares; 2026Q2: 460,067 shares; 2026Q3: 460,067 shares 460,067$1.25M0.82%0Timeline
PVLAPALVELLA THERAPEUTICS INC NEQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 7,809 shares 7,809$1.08M0.7%newTimeline
ASNDASCENDIS PHARMA A/SQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 6,573 shares; 2026Q3: 4,414 shares 4,414$1.01M0.66%-2,159Timeline
RAPPRAPPORT THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 29,381 shares 29,381$987K0.65%newTimeline
BLLNBILLIONTOONE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 8,983 shares 8,983$956K0.62%newTimeline
ZBIOZENAS BIOPHARMA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 80,730 shares; 2026Q2: 52,443 shares; 2026Q3: 34,341 shares 34,341$926K0.61%-18,102Timeline
REPLREPLIMUNE GROUP INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 54,738 shares; 2025Q1: 294,846 shares; 2025Q2: 397,846 shares; 2025Q3: 73,614 shares; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 40,361 shares; 2026Q3: 68,488 shares 68,488$907K0.59%+28,127Timeline
EQEQUILLIUM INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 552,956 shares; 2026Q3: 552,956 shares 552,956$899K0.59%0Timeline
ESTAESTABLISHMENT LABS HLDGS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 13,100 shares; 2025Q1: 13,100 shares; 2025Q2: 13,100 shares; 2025Q3: 13,100 shares; 2025Q4: 13,100 shares; 2026Q1: 13,100 shares; 2026Q2: 13,100 shares; 2026Q3: 13,100 shares 13,100$841K0.55%0Timeline
CLYMCLIMB BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 71,215 shares 71,215$817K0.53%newTimeline
NBPNOVABRIDGE BIOSCIENCESQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 1,439,604 shares; 2025Q4: 499,587 shares; 2026Q1: 576,960 shares; 2026Q2: 576,960 shares; 2026Q3: 576,960 shares 576,960$788K0.51%0Timeline
DRUGBRIGHT MINDS BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 10,110 shares; 2026Q3: 14,715 shares 14,715$733K0.48%+4,605Timeline
CMPXCOMPASS THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 276,165 shares; 2026Q3: 511,084 shares 511,084$532K0.35%+234,919Timeline
QTTBQ32 BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 62,589 shares 62,589$518K0.34%newTimeline
CAPRCAPRICOR THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 51,531 shares 51,531$488K0.32%newTimeline
QUREUNIQURE NVQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 22,090 shares; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 81,056 shares; 2026Q3: 18,300 shares 18,300$442K0.29%-62,756Timeline
ABUSARBUTUS BIOPHARMA CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 28,300 shares; 2025Q1: not reported; 2025Q2: 75,484 shares; 2025Q3: 75,484 shares; 2025Q4: 75,484 shares; 2026Q1: 75,484 shares; 2026Q2: 50,166 shares; 2026Q3: 50,166 shares 50,166$240K0.16%0Timeline
ADAGADAGENE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 1,060,221 shares; 2026Q1: 736,845 shares; 2026Q2: 488,293 shares; 2026Q3: 52,543 shares 52,543$168K0.11%-435,750Timeline

Sold out in Q3 2026

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
AGIOAGIOS PHARMACEUTICALS INC70,500$2.62Mshares
CBIOCRESCENT BIOPHARMA INC.127,769$2.3Mshares
AZNASTRAZENECA PLC12,045$2.25Mshares
INSMINSMED INC13,873$1.48Mshares
RLAYRELAY THERAPEUTICS INC47,531$889Kshares
GERNGERON CORP624,046$799Kshares

How Q3 2026 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001420506-26-002739 base2026-11-16